Ketamine in The News
We invite you to review some of the media coverage below highlighting the clinical use of ketamine. In the last decade, a great deal of clinical research has been conducted by leading institutions all over the world proving intravenous ketamine’s efficacy and safety in the treatment of major depression, bipolar depression, PTSD and severe anxiety as well as certain pain disorders. Yale University, The Mayo Clinic, Mt. Sinai Medical School, The National Institute of Mental Health, Massachusetts General Hospital, and The Black Dog Institute are just a few of those institutions who have conducted studies.